Literature DB >> 21731526

National oncology practice benchmark: an annual assessment of financial and operational parameters-2010 report on 2009 data.

Thomas R Barr1, Elaine L Towle.   

Abstract

Amid increases in costs and numbers of patients combined with decreasing or stagnant reimbursements from payers, many oncology practices are improving efficiency and decreasing costs. The National Oncology Practice Benchmark, a national survey of community practices, provides data to help practices improve and monitor progress as they adapt to the changing practice environment.

Entities:  

Year:  2011        PMID: 21731526      PMCID: PMC3071595          DOI: 10.1200/JOP.2011.000223

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  4 in total

1.  2009 national practice benchmark: report on 2008 data.

Authors:  Elaine L Towle; Thomas R Barr
Journal:  J Oncol Pract       Date:  2009-09       Impact factor: 3.840

2.  Key practice indicators in office-based oncology practices: 2007 report on 2006 data.

Authors:  John Akscin; Thomas R Barr; Elaine L Towle
Journal:  J Oncol Pract       Date:  2007-07       Impact factor: 3.840

3.  The 2007 national practice benchmark: results of a national survey of oncology practices.

Authors:  Thomas R Barr; Elaine L Towle; William M Jordan
Journal:  J Oncol Pract       Date:  2008-07       Impact factor: 3.840

4.  National practice benchmark: 2010 report on 2009 data.

Authors:  Elaine L Towle; Thomas R Barr
Journal:  J Oncol Pract       Date:  2010-09       Impact factor: 3.840

  4 in total
  10 in total

1.  Medicare reimbursement changes and the practice of oncology: understanding of the past is a key to the future.

Authors:  Jonas A de Souza; Gilberto de Lima Lopes
Journal:  J Oncol Pract       Date:  2011-09       Impact factor: 3.840

2.  State of oncology practice.

Authors:  John V Cox
Journal:  J Oncol Pract       Date:  2011-09       Impact factor: 3.840

3.  Commentary: can you replace something with nothing?

Authors:  David Eagle
Journal:  J Oncol Pract       Date:  2011-09       Impact factor: 3.840

4.  Oncology Practice Trends From the National Practice Benchmark, 2005 through 2010.

Authors:  Thomas R Barr; Elaine L Towle
Journal:  J Oncol Pract       Date:  2011-09       Impact factor: 3.840

5.  Assessment of risk evaluation and mitigation strategies in oncology: summary of the oncology risk evaluation and mitigation strategies workshop.

Authors:  James N Frame; Joseph O Jacobson; Wendy H Vogel; Niesha Griffith; Darshan Wariabharaj; Rekha Garg; Robin Zon; Cyntha L Stephens; Alison M Bialecki; Suanna S Bruinooge; Steven L Allen
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840

6.  Oncology practice trends from the national practice benchmark.

Authors:  Thomas R Barr; Elaine L Towle
Journal:  J Oncol Pract       Date:  2012-09       Impact factor: 3.840

7.  Medical oncologists' perceptions of financial incentives in cancer care.

Authors:  Jennifer L Malin; Jane C Weeks; Arnold L Potosky; Mark C Hornbrook; Nancy L Keating
Journal:  J Clin Oncol       Date:  2012-12-26       Impact factor: 44.544

8.  Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline.

Authors:  Vijay Patil; Vanita Noronha; Amit Joshi; Purvish Parikh; Atanu Bhattacharjee; Santam Chakraborty; Sunny Jandyal; Vamshi Muddu; Anant Ramaswamy; K Govinda Babu; Nilesh Lokeshwar; Sachin Hingmire; Nikhil Ghadyalpatil; Shripad Banavali; Kumar Prabhash
Journal:  J Glob Oncol       Date:  2016-11-09

Review 9.  Benchmarking facilities providing care: An international overview of initiatives.

Authors:  Frédérique Thonon; Jonathan Watson; Mahasti Saghatchian
Journal:  SAGE Open Med       Date:  2015-09-23

Review 10.  Choosing wisely in oncology: necessity and obstacles.

Authors:  Piercarlo Saletti; Piero Sanna; Luca Gabutti; Michele Ghielmini
Journal:  ESMO Open       Date:  2018-07-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.